Amyris and Solazyme Shares Surge as Alternative Fuels Tax Credit Extended Through 2013

Five Star Equities Provides Stock Research on Amyris and Solazyme

Continue Reading

Chinese Solar Stocks on an Impressive Run to Start the Year After a Dismal 2012

The Paragon Report Provides Stock Research on LDK Solar and Trina Solar

Continue Reading

Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits

Five Star Equities Provides Stock Research on Renewable Energy Group and Gevo

Continue Reading

Gold Prices Surge as Deal to Avoid Fiscal Cliff “Within Sight”

The Paragon Report Provides Stock Research on Eldorado Gold and Kinross Gold

Continue Reading

Gold Posts 12th Consecutive Year of Gains With a 6% Increase in 2012

The Paragon Report Provides Stock Research on Yamana Gold and New Gold

Continue Reading

S&P 500 Index Posts a 13.4% Gain in 2012 — The Largest Since 2009

The Paragon Report Provides Stock Research on Caterpillar and Halliburton

Continue Reading

S&P 500 Index Posts Best Year Since 2009 — Bristol Myers Squibb and Johnson & Johnson Receive FDA Approvals

The Paragon Report Provides Stock Research on Bristol Myers Squibb and Johnson & Johnson

Continue Reading

China-s Sets First Round of 2013 Rare Earth Exports 27% Below 2012

Five Star Equities Provides Stock Research on Molycorp and Lynas

Continue Reading

Rare Industry Continues to Struggle With Low Prices and New Supplies — China Sets 2013 Rare Earth Exports Quotas

Five Star Equities Provides Stock Research on Rare Element Resources and Quest Rare Minerals

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Vical

Continue Reading